| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(78)92101-3 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673678921013?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0140673678921013?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 82736 |
| P2093 | author name string | R. B. Layzer | |
| P2860 | cites work | Lhermitte's sign in subacute combined degeneration of the cord | Q37094607 |
| Megaloblastic haemopoiesis in patients receiving nitrous oxide | Q39502285 | ||
| Trace contamination of anesthetic gases: a brief review | Q39696717 | ||
| Control of occupational exposure to nitrous oxide in the dental operatory | Q39828545 | ||
| Degeneration in central and peripheral nervous systems produced by pure n-hexane: an experimental study | Q40025938 | ||
| Polyneuropathy from inhalation of N2O cartridges through a whippedcream dispenser | Q40141964 | ||
| Neuropathy following abuse of nitrous oxide | Q40141970 | ||
| Subacute myelo-optic neuropathy in Australia | Q42230401 | ||
| An evaluation of prolonged nitrous oxide-oxygen sedation in rats | Q48499750 | ||
| Testicular Reaction to Prolonged Exposure to Nitrous Oxide | Q52713444 | ||
| Treatment of tetanus; severe bone-marrow depression after prolonged nitrous-oxide anaesthesia. | Q52775669 | ||
| Mercury Poisoning and Its Treatment withn-Acetyl-d,l-Penicillamine | Q70521640 | ||
| P433 | issue | 8102 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | substance-related disorder | Q4134457 |
| dentist | Q27349 | ||
| P304 | page(s) | 1227-1230 | |
| P577 | publication date | 1978-12-01 | |
| 1978-12-09 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Myeloneuropathy after prolonged exposure to nitrous oxide | |
| P478 | volume | 2 |
| Q48872288 | "Whippets"-induced cobalamin deficiency manifesting as cervical myelopathy |
| Q43784572 | A dysmethylation syndrome, bound to folates and/or vitamin B12 and/or methionine abnormalities? Diagnosis, prevention and treatment considerations |
| Q38020430 | A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome |
| Q30811595 | A review on radiogenic Lhermitte's sign |
| Q51786021 | A survey of nitrous oxide levels in dental offices. |
| Q30304432 | Adolescent inhalant abuse: environments of use. |
| Q35453554 | Adverse effects of general anaesthetics |
| Q39749538 | Adverse effects of nitrous oxide |
| Q39101778 | An equivalence study comparing nitrous oxide and oxygen with low-dose sevoflurane and oxygen as inhalation sedation agents in dentistry for adults |
| Q41268030 | An evaluation of air safety source-control technology for the post anesthesia care unit |
| Q37974174 | An introduction to the clinical toxicology of volatile substances |
| Q46261633 | Anaesthesia and alcohol |
| Q36600968 | Anaesthetic considerations for microsurgical repair of limbs |
| Q39017925 | Approach to a case of myeloneuropathy |
| Q90003321 | Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review |
| Q40984150 | Chronic cobalamin inactivation impairs folate polyglutamate synthesis in the rat |
| Q34045039 | Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology |
| Q39768344 | Clinical pharmacokinetics of the inhalational anaesthetics |
| Q36075598 | Cobalamin and folate: recent developments |
| Q28645919 | Cobalamins and nitrous oxide: a review |
| Q51436198 | Cost analysis of xenon anesthesia: a comparison with nitrous oxide-isoflurane and nitrous oxide-sevoflurane anesthesia. |
| Q39376238 | Disorders of cobalamin metabolism |
| Q51762918 | Displacement of small bowel from pelvic radiation field. |
| Q51684598 | Exposure of operating room personnel to nitrous oxide during paediatric anaesthesia |
| Q51853052 | Exposure to anesthetic gases: a controversy. |
| Q42849325 | Folate polyglutamate synthetase activity in the cobalamin-inactivated rat. |
| Q51738285 | Formate metabolism in the cobalamin-inactivated rat. |
| Q36238425 | General anesthesia in cardiac surgery: a review of drugs and practices. |
| Q34586192 | Health hazards and nitrous oxide: a time for reappraisal |
| Q84978800 | Hypocupremia: an under recognized cause of subacute combined degeneration |
| Q42912294 | Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. |
| Q30456090 | Is nitrous oxide necessary in the future? |
| Q68461777 | Isoflurane for conscious sedation |
| Q34195395 | Laboratory evaluation of anemia |
| Q37612909 | Lhermitte's sign and vitamin B12 deficiency: case report |
| Q51854610 | Local cerebral glucose utilization in two models of B12 deficiency. |
| Q39689320 | Megaloblastic anaemia in the elderly |
| Q51860739 | Megaloblastic haemopoiesis after multiple short-term exposure to nitrous oxide |
| Q40931029 | Metabolite assays in cobalamin and folate deficiency |
| Q41096820 | Methionine in the treatment of nitrous-oxide-induced neuropathy and myeloneuropathy |
| Q67292849 | Myeloneuropathy due to nitrous oxide |
| Q42550519 | Myeloneuropathy from whipped cream bulbs presenting as conversion disorder |
| Q28645920 | N2O and Urine Methylmalonic Acid in Man |
| Q49043926 | Nanging |
| Q38796169 | Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature |
| Q40931054 | Neurological complications of acquired cobalamin deficiency: clinical aspects |
| Q37017900 | Neurological involvement in hereditary transcobalamin II deficiency |
| Q34737044 | Neuromuscular diseases and disorders of the alimentary system |
| Q51599058 | Neurotoxicity from overuse of nitrous oxide |
| Q48243678 | Neurotoxicity of nitrous oxide: multimodal evoked potentials in an abuser |
| Q47636537 | Nitrous Oxide Abuse and Vitamin B12 Action in a 20-Year-Old Woman: A Case Report |
| Q36359555 | Nitrous oxide |
| Q36836041 | Nitrous oxide and oral premedication. |
| Q90483616 | Nitrous oxide and vitamin B12 in sickle cell disease: Not a laughing situation |
| Q35243758 | Nitrous oxide anesthesia and plasma homocysteine in adolescents |
| Q97425661 | Nitrous oxide as a putative novel dual-mechanism treatment for bipolar depression: Proof-of-concept study design and methodology |
| Q24601851 | Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats |
| Q35128018 | Nitrous oxide in emergency medicine |
| Q48787277 | Nitrous oxide inhalation as a cause of cervical myelopathy |
| Q45076980 | Nitrous oxide mood disorder |
| Q41391369 | Nitrous oxide sedation/analgesia in emergency medicine |
| Q34594467 | Nitrous oxide-induced vitamin B(12) deficiency |
| Q45022219 | Nitrous oxide. Sense or nonsense for today's anaesthesia |
| Q54940377 | No laughing matter: subacute degeneration of the spinal cord due to nitrous oxide inhalation. |
| Q51874124 | Occupational hazards of anesthesia. |
| Q28386197 | Occupational peripheral neuropathies |
| Q51842787 | Operating room workers: between Scylla and Charybdis. |
| Q51438041 | Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MAC sevoflurane for 8 hours. |
| Q48520240 | Persistent cognitive functioning deficits in operating rooms: two cases |
| Q51241145 | Personality, prior drug use, and introspective experience during nitrous oxide intoxication. |
| Q40087979 | Pharmacosexology: the effects of drugs on sexual function a review |
| Q51756182 | Replacing analgesic nitrous oxide with a dangerous alternative. |
| Q40393703 | S-adenosylmethionine levels in psychiatric and neurological disorders: a review |
| Q47802714 | Severe motor neuropathy or neuronopathy due to nitrous oxide toxicity after correction of vitamin B12 deficiency |
| Q51418711 | Sickle cell disease and nitrous oxide-induced neuropathy. |
| Q88658984 | Subacute Combined Degeneration from Nitrous Oxide Abuse in a Patient with Pernicious Anemia |
| Q34603602 | Subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia |
| Q51273214 | Subjective Effects of Nitrous Oxide: Cognitive, Emotional, Perceptual and Transcendental Experiences |
| Q39432914 | Substance abuse: clinical identification and management |
| Q64119383 | The MEOPAeDent trial protocol-an observational study of the Equimolar Mixture of Oxygen and Nitrous Oxide (EMONO) effects in paediatric dentistry |
| Q51876764 | The deliberate inhalation of volatile substances. |
| Q41644847 | The effect of nitrous oxide inactivation of vitamin B12 on rat hepatic folate. Implications for the methylfolate-trap hypothesis |
| Q48301346 | The effects of nitrous oxide after exposure during middle and late gestation |
| Q34707301 | The effects of nitrous oxide on cobalamins, folates, and on related events |
| Q33934512 | The pathogenesis of the neurological complications of HIV-1 infection. |
| Q51638074 | The subjective, behavioral and cognitive effects of subanesthetic concentrations of isoflurane and nitrous oxide in healthy volunteers. |
| Q71675740 | The visual-evoked potential in tobacco-alcohol and nutritional amblyopia |
| Q34490594 | Toxicity of bone marrow in dentists exposed to nitrous oxide |
| Q38063024 | Transverse myelitis |
| Q47586387 | Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. |
| Q40502046 | Vitamin B12 and the B12 coenzymes. |
| Q34575356 | Vitamin B12, folic acid, and the nervous system |
| Q73850475 | Volatile substance abuse |
| Q38104627 | Volatile substance misuse: an updated review of toxicity and treatment |
| Q30444204 | When nitrous oxide is no laughing matter: nitrous oxide and pediatric anesthesia |
| Q33716735 | Xenon: recent developments |
| Q80088566 | [Nitric-oxide triggered neurological disorders in subjects with vitamin B12 deficiency] |
Search more.